Viridian Therapeutics, Inc. (VRDN) Earnings
|
Expand Research on VRDN
| Next EPS Date | 8/12/26 | EPS Growth Rate | +3.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +23.3% | Revenue Growth Rate | +12,766.7% |
| Average % Move 1-Wk after EPS | +6.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.97 | N/A | N/A | $9.65M | N/A | N/A | N/A | ||
| 5/5/26 |
Q126 | -$0.90 | -$1.08 | +$0.18 | $140K | $33.31K | N/A |  | | Details | |
| 2/26/26 |
Q425 | -$0.34 | -$0.98 | +$0.64 | $70.57M | $18.38M | N/A | | | Details | |
| 11/18/25 |
Q325 | N/A | -$0.95 | N/A | N/A | $30.33K | N/A | N/A | N/A | ||
| 8/6/25 | Q225 | -$1.00 | -$1.00 | $0.00 | $75K | $50.92K | N/A | | | Details | |
| 5/6/25 |
Q125 | -$0.87 | -$0.98 | +$0.11 | $70K | $52.09K | N/A | | | Details | |
| 2/27/25 | Q424 | -$0.81 | -$1.03 | +$0.22 | $72K | $50.92K | N/A | | | Details | |
| 2/26/25 |
Q424 | N/A | -$1.03 | N/A | N/A | $50.92K | N/A | N/A | N/A |
